Testing effectiveness (Phase 2)UnknownNCT06569459
What this trial is testing
Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer
Who this might be right for
Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University 60